Lenvatinib ist Sorafenib in der Zweitlinie überlegen

InFo Hämatologie + Onkologie 2026

View at publisher
Authors: Johannes Niemeyer, Aaron Schindler
DOI: 10.1007/s15004-026-1253-5
Cited by: 0
References: 4

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Colorectal Cancer Treatments and Studies Renal cell carcinoma treatment

Publication details

Journal / source
InFo Hämatologie + Onkologie
Volume
29
Issue
1
Pages
26–27
Publication date
1 February 2026
Language
DE